Gottlieb describes shutdown impacts, new safety initiatives

FDA will inspect fewer medical product facilities and will not hit its 2019 goals for reviewing medical product imports as a result of the 35-day funding lapse, FDA Commissioner Scott Gottlieb told Congress Wednesday. He also described new initiatives in

Read the full 400 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE